Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending October 22, 2021

Overall drug TRx -0.4% w/w

Vascepa
TRx 80,875; +2.3% (+1,795) w/w; -17.8% y/y
NRx 36,464; +2.7% (+946) w/w; -20.8% y/y
Ref 44,411; +2.0% (+850) w/w; -15.1% y/y

Lovaza (Generic & Brand)
TRx 62,779; +1.6% (+1,018) w/w; -4.4% y/y
NRx 30,748; +3.2% (+961) w/w; -11.0% y/y
Ref 32,031; +0.2% (+57) w/w; +3.1% y/y

Generic Vascepa
TRx 20,632; +1.4% (+279) w/w; As % of total V: 20.3%
NRx 11,829; +2.0% (+231) w/w; As % of total V: 24.5%
Ref 8,803; +0.2% (+57) w/w; As % of total V: 16.5%

Generic Vascepa by Manufacturer
Hikma - TRx 12,802 (-51); Generic share 62.0%; Total V share 12.6%
Reddy - TRx 7,830 (+329); Generic share 38.0%; Total V share 7.7%

TRx Vascepa + Generic Vascepa
TRx 101,507; +2.1% (+2,074)
NRx 48,293; +2.5% (+1,177)
Ref 53,215; +1.7% (+897)